Pacira BioSciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $-22.9M | $7.1M |
| FY2010 | $21.9M | $-48.4M | $26.1M |
| FY2011 | $18.5M | $48.3M | $46.2M |
| FY2012 | $25.2M | $65.9M | $12.5M |
| FY2013 | $0 | $41.2M | $12.5M |
| FY2014 | $103.1M | $171.1M | $37.5M |
| FY2015 | $104.0M | $218.4M | $57.0M |
| FY2016 | $108.7M | $219.0M | $35.9M |
| FY2017 | — | $279.5M | $54.1M |
| FY2018 | — | $321.2M | $132.5M |
| FY2019 | — | $354.9M | $78.2M |
| FY2020 | — | $619.7M | $100.0M |
| FY2021 | — | $730.4M | $585.6M |
| FY2022 | $689.5M | $775.0M | $104.1M |
| FY2023 | $522.4M | $870.1M | $153.3M |
| FY2024 | $383.5M | $778.3M | $276.8M |
| FY2025 | $372.2M | $693.1M | $158.5M |